Literature DB >> 15522883

Identification of the namH gene, encoding the hydroxylase responsible for the N-glycolylation of the mycobacterial peptidoglycan.

Jon B Raymond1, Sebabrata Mahapatra, Dean C Crick, Martin S Pavelka.   

Abstract

The peptidoglycan of most bacteria consists of a repeating disaccharide unit of beta-1,4-linked N-acetylmuramic acid and N-acetylglucosamine. However, the muramic acid moieties of the mycobacterial peptidoglycan are N-glycolylated, not N-acetylated. This is a rare modification seen only in the peptidoglycan of mycobacteria and five other closely related genera of bacteria. The N-glycolylation of sialic acids is a unique carbohydrate modification that has been studied extensively in eukaryotes. However, the significance of the N-glycolylation of bacterial peptidoglycan is unknown. The goal of this project was to identify the gene encoding the hydroxylase responsible for the N-glycolylation of the mycobacterial peptidoglycan. We developed a novel assay for the mycobacterial UDP-N-acetylmuramic acid hydroxylation reaction and demonstrated that Mycobacterium smegmatis has an enzyme activity that can convert UDP-N-acetylmuramic acid to UDP-N-glycolylmuramic acid. We identified the gene namH encoding the mycobacterial UDP-N-acetylmuramic acid hydroxylase by computer data base searching and motif comparisons with the eukaryotic enzymes responsible for the N-glycolyation of sialic acids. The namH gene is not essential for in vitro growth as we were successful in deleting the gene in M. smegmatis. The M. smegmatis mutant is devoid of UDP-N-acetylmuramic acid hydroxylase activity and synthesizes only N-acetylated muropeptide precursors. Furthermore, the mutant exhibits increased susceptibility to beta-lactam antibiotics and lysozyme. Our studies suggest that the N-glycolylation of mycobacterial peptidoglycan may play a role in lysozyme resistance or may contribute to the structural stability of the cell wall architecture.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15522883     DOI: 10.1074/jbc.M411006200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

Review 1.  Lysozymes in the animal kingdom.

Authors:  Lien Callewaert; Chris W Michiels
Journal:  J Biosci       Date:  2010-03       Impact factor: 1.826

Review 2.  Modifications to the peptidoglycan backbone help bacteria to establish infection.

Authors:  Kimberly M Davis; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

3.  Differential Peptidoglycan Recognition Assay Using Varied Surface Presentations.

Authors:  Elizabeth A D'Ambrosio; Klare L Bersch; Mackenzie L Lauro; Catherine L Grimes
Journal:  J Am Chem Soc       Date:  2020-06-16       Impact factor: 15.419

4.  Deception point: peptidoglycan modification as a means of immune evasion.

Authors:  Jennifer L Bishop; Erin C Boyle; B Brett Finlay
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-12       Impact factor: 11.205

Review 5.  Targeting the formation of the cell wall core of M. tuberculosis.

Authors:  Clifton E Barry; Dean C Crick; Michael R McNeil
Journal:  Infect Disord Drug Targets       Date:  2007-06

6.  Genetic characterization of mycobacterial L,D-transpeptidases.

Authors:  Akeisha N Sanders; Lori F Wright; Martin S Pavelka
Journal:  Microbiology (Reading)       Date:  2014-05-21       Impact factor: 2.777

7.  Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.

Authors:  M Salem; J B Seidelin; S Eickhardt; M Alhede; G Rogler; O H Nielsen
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

8.  Biosynthesis of a water-soluble lipid I analogue and a convenient assay for translocase I.

Authors:  Shajila Siricilla; Katsuhiko Mitachi; Karolina Skorupinska-Tudek; Ewa Swiezewska; Michio Kurosu
Journal:  Anal Biochem       Date:  2014-06-02       Impact factor: 3.365

9.  Meropenem inhibits D,D-carboxypeptidase activity in Mycobacterium tuberculosis.

Authors:  Pradeep Kumar; Kriti Arora; John R Lloyd; Ill Y Lee; Vinod Nair; Elizabeth Fischer; Helena I M Boshoff; Clifton E Barry
Journal:  Mol Microbiol       Date:  2012-08-28       Impact factor: 3.501

10.  Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.

Authors:  François Coulombe; Maziar Divangahi; Frédéric Veyrier; Louis de Léséleuc; James L Gleason; Yibin Yang; Michelle A Kelliher; Amit K Pandey; Christopher M Sassetti; Michael B Reed; Marcel A Behr
Journal:  J Exp Med       Date:  2009-07-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.